BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018

被引：46

作者：

Brady, Michael ^{[1
]}

Rodger, Alison ^{[2
]}

Asboe, David ^{[3
]}

Cambiano, Valentina ^{[4
]}

Clutterbuck, Dan ^{[5
]}

Desai, Monica ^{[6
]}

Field, Nigel ^{[7
]}

Harbottle, Justin ^{[8
]}

Jamal, Zahra ^{[9
]}

McCormack, Sheena ^{[10
]}

Palfreeman, Adrian ^{[11
]}

Portman, Mags ^{[12
]}

Quinn, Killian ^{[1
]}

Tenant-Flowers, Melinda ^{[13
]}

Wilkins, Ed ^{[14
]}

Young, Ingrid ^{[15
]}

机构：

[1] Kings Coll Hosp London, Sexual Hlth & HIV, London, England

[2] UCL, Infect Dis & HIV, London, England

[3] Chelsea & Westminster Hosp NHS Fdn Trust, HIV & Sexual Hlth, London, England

[4] UCL, Infect Dis Modelling & Biostat, London, England

[5] NHS Lothian, HIV & Sexual Hlth, Edinburgh, Midlothian, Scotland

[6] Publ Hlth England, London, England

[7] UCL, London, England

[8] Terrence Higgins Trust, London, England

[9] NAZ, London, England

[10] UCL, MRC Clin Trials Unit, Clin Epidemiol, London, England

[11] Univ Hosp Leicester NHS Trust, HIV & Sexual Hlth, Leicester, Leics, England

[12] Mortimer Market Ctr, HIV & Sexual Hlth, London, England

[13] Kings Coll Hosp London, HIV & Sexual Hlth Med, London, England

[14] North Manchester Gen Hosp, Infect Dis, Manchester, Lancs, England

[15] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland

来源：

HIV MEDICINE | 2019年 / 20卷

关键词：

TENOFOVIR DISOPROXIL FUMARATE; SEXUAL RISK BEHAVIOR; DEPOT MEDROXYPROGESTERONE ACETATE; COST-EFFECTIVENESS ANALYSIS; BONE-MINERAL DENSITY; UNITED-STATES; ANTIRETROVIRAL THERAPY; TRANSGENDER WOMEN; DRUG-RESISTANCE; ORAL TENOFOVIR;

D O I：

10.1111/hiv.12718

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：S2 / S80

页数：79

共 50 条

[1] HIV pre-exposure prophylaxis (PrEP)
Tumarkin, Ethan
Siedner, Mark J.
Bogoch, Isaac I.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
[2] PrEP: pre-exposure prophylaxis for HIV prevention
Page, Matthew
Nicholls, Jane
[J]. TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 22 - 24
[3] Barriers to Pre-Exposure Prophylaxis (PrEP) use for HIV: an integrative review
Antonini, Marcela
da Silva, Ingred Evangelista
Elias, Henrique Ciabotti
Gerin, Larissa
Oliveira, Aliete Cunha
Reis, Renata Karina
[J]. REVISTA BRASILEIRA DE ENFERMAGEM, 2023, 76 (03)
[4] HIV pre-exposure prophylaxis (PrEP); [Pre-expositieprofylaxe tegen hiv (PrEP)]
Hermanussen R.
[J]. Huisarts en wetenschap, 2017, 60 (6) : 264 - 267
[5] Pre-exposure HIV prophylaxis (PrEP) background and controversies
Zalewski, Bartlomiej M.
Jablonska, Monika
Mikula, Tomasz
[J]. HIV & AIDS REVIEW, 2009, 8 (04): : 8 - 10
[6] State of the Science - HIV Pre-Exposure Prophylaxis (PrEP)
Chariyalertsak, S.
[J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E9 - E10
[7] Pre-exposure prophylaxis (PrEP)
Bradshaw, Helen
[J]. HIV MEDICINE, 2021, 22 : 47 - 47
[8] PrEP Whores and HIV Prevention: The Queer Communication of HIV Pre-Exposure Prophylaxis (PrEP)
Spieldenner, Andrew
[J]. JOURNAL OF HOMOSEXUALITY, 2016, 63 (12) : 1685 - 1697
[9] Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Gaspar, Mark
Salway, Travis
Grace, Daniel
[J]. SOCIAL THEORY & HEALTH, 2022, 20 (02) : 171 - 187
[10] HIV Pre-Exposure Prophylaxis (PrEP)-A Quantitative Ethics Appraisal
Kokolo, Madzouka B.
Fergusson, Dean A.
Cameron, D. William
[J]. PLOS ONE, 2011, 6 (08):

← 1 2 3 4 5 →